Journal article

Factors associated with future intentions to use personal vaporisers among those with some experience of vaping

Bernice Hua Ma, Hua-Hie Yong, Ron Borland, Ann McNeill, Sara C Hitchman

DRUG AND ALCOHOL REVIEW | WILEY | Published : 2018

Abstract

INTRODUCTION AND AIMS: Personal vaporisers (PV), including e-cigarettes, may be a harm reduction strategy for tobacco control. This study aims to identify factors associated with future intentions to vape among smokers and ex-smokers in Australia and the UK. DESIGN AND METHODS: Cross-sectional data of smokers and ex-smokers (n = 1199, mean age = 45.3 years, 44.8% male), collected in 2014/2015 and divided into four subgroups: smoking past vapers (SPV), smoking vapers (SV), ex-smoking past vapers (ESPV) and ex-smoking vapers (ESV), from the International Tobacco Control Australia and UK surveys were analysed by using regression models. RESULTS: Higher vaping satisfaction increased vaping inten..

View full abstract

Grants

Awarded by US National Cancer Institute


Awarded by Medical University of South Carolina, Charleston, South Carolina


Awarded by Canadian Institutes of Health Research


Awarded by National Health and Medical Research Council of Australia


Awarded by National Institute for Health Research under UK Clinical Research Collaboration


Awarded by Cancer Research UK


Awarded by NATIONAL CANCER INSTITUTE


Funding Acknowledgements

Ethics approval for the study was obtained from the relevant institutional Ethic Committees at the University of Waterloo, the Cancer Council Victoria, Australia and King's College London, UK. The ITC-4 survey was supported by multiple grants from the US National Cancer Institute, including R01 CA100362 and P50 CA111236 and also in part from grants P01 CA138389 and P01 CA200512 (Medical University of South Carolina, Charleston, South Carolina). Additional grant support was provided by the Canadian Institutes of Health Research (79551 and 115016) and the National Health and Medical Research Council of Australia (1005922 and 1106451). AM and SH are members of the UK Centre for Tobacco and Alcohol Studies, a UK Clinical Research Collaboration Public Health Research: Centre of Excellence whose work is supported by funding from the Medical Research Council, British Heart Foundation, the Economic and Social Research Council and the National Institute for Health Research under the auspices of the UK Clinical Research Collaboration (MR/K023195/1). AM and SH are also funded by Cancer Research UK (C25586/A19540). None of the authors has any conflict of interest to declare.